Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 2
1948 1
1949 3
1950 6
1951 1
1952 6
1953 1
1954 1
1955 2
1956 1
1957 6
1958 7
1959 3
1960 3
1961 3
1962 3
1963 3
1964 1
1965 9
1966 2
1967 2
1968 3
1969 4
1970 2
1971 5
1972 5
1973 6
1974 2
1975 2
1976 1
1977 4
1978 3
1979 2
1980 2
1981 2
1982 2
1983 3
1984 3
1985 8
1986 7
1987 11
1988 8
1989 11
1990 8
1991 6
1992 7
1993 7
1994 4
1995 2
1996 3
1997 7
1998 6
2000 3
2001 4
2002 4
2005 3
2006 3
2007 4
2008 1
2009 3
2010 3
2011 2
2012 4
2013 4
2014 3
2015 4
2016 5
2017 4
2018 2
2020 5
2021 6
2022 1
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

273 results

Results by year

Filters applied: . Clear all
Page 1
Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia.
Hochhaus A, Larson RA, Guilhot F, Radich JP, Branford S, Hughes TP, Baccarani M, Deininger MW, Cervantes F, Fujihara S, Ortmann CE, Menssen HD, Kantarjian H, O'Brien SG, Druker BJ; IRIS Investigators. Hochhaus A, et al. N Engl J Med. 2017 Mar 9;376(10):917-927. doi: 10.1056/NEJMoa1609324. N Engl J Med. 2017. PMID: 28273028 Free PMC article. Clinical Trial.
Impact of rituximab on COVID-19 outcomes.
Levavi H, Lancman G, Gabrilove J. Levavi H, et al. Among authors: gabrilove j. Ann Hematol. 2021 Nov;100(11):2805-2812. doi: 10.1007/s00277-021-04662-1. Epub 2021 Sep 22. Ann Hematol. 2021. PMID: 34549309 Free PMC article.
Colony-stimulating factors.
Gordon MS, Gabrilove JL. Gordon MS, et al. Among authors: gabrilove jl. Curr Opin Oncol. 1990 Dec;2(6):1152-8. doi: 10.1097/00001622-199012000-00021. Curr Opin Oncol. 1990. PMID: 1712236 Review. No abstract available.
Ibrutinib dose modifications in the management of CLL.
Hardy-Abeloos C, Pinotti R, Gabrilove J. Hardy-Abeloos C, et al. Among authors: gabrilove j. J Hematol Oncol. 2020 Jun 5;13(1):66. doi: 10.1186/s13045-020-00870-w. J Hematol Oncol. 2020. PMID: 32503582 Free PMC article. Review.
Filgrastim (r-metHuG-CSF): the first 10 years.
Welte K, Gabrilove J, Bronchud MH, Platzer E, Morstyn G. Welte K, et al. Among authors: gabrilove j. Blood. 1996 Sep 15;88(6):1907-29. Blood. 1996. PMID: 8822908 Free article. Review. No abstract available.
Endocrinology.
SOFFER LJ, GABRILOVE JL. SOFFER LJ, et al. Among authors: gabrilove jl. Annu Rev Med. 1954;5:115-66. doi: 10.1146/annurev.me.05.020154.000555. Annu Rev Med. 1954. PMID: 13181372 No abstract available.
Creating effective career development programs.
Rubio DM, Robinson GFWB, Gabrilove J, Meagher EA. Rubio DM, et al. Among authors: gabrilove j. J Clin Transl Sci. 2017 Apr;1(2):83-87. doi: 10.1017/cts.2016.30. Epub 2017 Apr 18. J Clin Transl Sci. 2017. PMID: 28649449 Free PMC article.
273 results